Joseph Lyssikatos

Founder at ENLIVEN THERAPEUTICS, INC.

Net worth: 39 M $ as of 29/06/2026

61 year

Health Technology

Consumer Services

Profile

Joseph P.
Lyssikatos is the founder of Enliven Therapeutics, Inc., founded in 2019, where the title held is Chief Scientific Officer since 2024.
Dr. Lyssikatos is also the founder of Enliven Therapeutics, Inc...
Former jobs include Executive Director-Discovery at Stemcentrx, Inc. from 2017 to 2019, Executive Director at AbbVie, Inc., Senior Director at Array BioPharma, Inc., Head-Staff Scientist at Genentech, Inc., Vice President-Medicinal Chemistry & DMPK at Biogen, Inc. from 2014 to 2015, and Denali Fellow at Denali Therapeutics, Inc. from 2017 to 2019.
Education includes undergraduate studies at The College of William & Mary and a doctorate from the University of California, Berkeley.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ENLIVEN THERAPEUTICS, INC. 1.06%	11/02/2026	758,938 ( 1.06% )	39 M $	29/06/2026

Joseph Lyssikatos active positions

Companies	Position	Start
ENLIVEN THERAPEUTICS, INC.	Founder	31/05/2019
Enliven Therapeutics, Inc. /US/ Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer	Founder	-

All active positions of Joseph Lyssikatos

Former positions of Joseph Lyssikatos

Companies	Position	End
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Corporate Officer/Principal	31/05/2019
DENALI THERAPEUTICS INC.	Corporate Officer/Principal	31/05/2019
BIOGEN INC.	Corporate Officer/Principal	31/10/2015
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Corporate Officer/Principal	-
ARRAY TECHNOLOGIES, INC.	Director/Board Member	-

See the detail of Joseph Lyssikatos's experience

Training of Joseph Lyssikatos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Lyssikatos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Array BioPharma, Inc. Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs	Health Technology
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Health Technology
AbbVie, Inc. AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies	Health Technology
The College of William & Mary The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Denali Therapeutics, Inc. Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases	Health Technology
Enliven Therapeutics, Inc. /US/ Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer	Health Technology
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies	Health Technology